TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Indiana Investigators

Thomas I. Jones, MD

Clarian Arnett Cancer Care


Lafayette, Indiana - 47904 (765-448-7500)

Arnett Cancer Care


Lafayette, Indiana - 47904 (765-448-7500)
  • CLINICAL TRIALS 14
  • CONDITIONS21
  • INTERVENTIONS38
  • SINCE2003
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement

March 2009 - May 2015
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

January 2008 - February 2010
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

June 2010 - February 2013
Efficacy and Safety of Nipent Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

January 2003 - April 2009
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer

July 2005 - October 2012
Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

February 2008 - August 2009
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer

May 2008 - February 2009
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

November 2005 - June 2008
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative HER2-Negative Breast Cancer

May 2009 - January 2022
Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

September 2009 - January 2011
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

July 2009 - August 2011
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

June 2007 - July 2015
A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

September 2005 - December 2010
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Adenocarcinoma

Prostatic Neoplasms

Multiple Myeloma

Neoplasms, Plasma Cell

Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphoid

Neoplasms

Neoplasm Metastasis

Urinary Bladder Neoplasms

Kidney Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Small Cell

Colorectal Neoplasms

Carcinoma, Transitional Cell

Ureteral Neoplasms

Urologic Neoplasms

Urethral Neoplasms

Placebo

Melphalan

Biopsy

Zoledronic Acid

Celecoxib

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Gemcitabine Hydrochloride

Cyclophosphamide

Prednisone

Lenalidomide

Pemetrexed Disodium

Capecitabine

Oxaliplatin

Doxorubicin Hydrochloride

Etoposide

Zd6474

Gemcitabine

Pegfilgrastim

Cixutumumab

Thalidomide

Cetuximab

Doxorubicin

Tamoxifen Citrate

Irinotecan Hydrochloride

Letrozole

Ac Regimen

Nipent, Cytoxan, Rituxan

Vinorelbine Ditartrate

Placebo Administration

Vinorelbine

Serum Collection

Urine Collection

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo